Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Use of genetically modified T-lymphocytes expressing the inducible human caspase 9 gene (iCASP9) and the selection gene ΔCD19 for the treatment of Graft versus Host Disease (GvHD) in allogeneic haematopoietic transplantation: Study Side by Cide

Proposed period of release:
01/03/2014 to 30/03/2017

Name of the Institute(s) or Company(ies)
Centre Hospitalier Universitaire de Besançon, ;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
RNA Virus

Identity of the GMO:
Human T lymphocytes expressing the iCasp9 (suicide gene) and ΔCD19 cell surface marker (selection gene).

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known